My approach to the diagnosis of mesothelial lesions
Open Access
- 10 February 2006
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 59 (6), 564-574
- https://doi.org/10.1136/jcp.2005.029652
Abstract
Mesothelial lesions pose considerable diagnostic challenges not only because benign tumours, reactive proliferations and malignant mesothelioma can mimic one another, but also because the morphological patterns displayed by malignant mesothelioma can simulate a variety of epithelial and non-epithelial malignancies. Immunohistochemical markers can aid in distinguishing epithelioid malignant mesothelioma from metastatic adenocarcinoma, but because no single marker reliably separates all cases, a panel of stains is recommended. Immunohistochemical studies are of more limited value in sarcomatoid malignant mesothelioma, and other features often play an essential role. The separation of reactive mesothelial proliferations from malignant mesothelioma on small biopsy can be quite difficult, as distinguishing features, such as stromal invasion, often cannot be adequately assessed. In adequately sampled lesions, however, the distinction between malignant mesothelioma, benign mesothelial proliferations and other tumours can be achieved in most cases by using a carefully intergrated approach that incorporates clinical and radiographic data, immunohistochemical studies and, in selected cases, histochemical and ultrastructural techniques.Keywords
This publication has 83 references indexed in Scilit:
- The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative studyLaboratory Investigation, 2006
- Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarrayGynecologic Oncology, 2004
- Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesotheliumThe Journal of Pathology, 2003
- Expression of Calretinin, Thrombomodulin, Keratin 5, and Mesothelin in Lung Carcinomas of Different TypesThe American Journal of Surgical Pathology, 2003
- Primary thymic epithelial tumours of the pleura mimicking malignant mesotheliomaHistopathology, 2002
- Lymphohistiocytoid MesotheliomaAmerican Journal of Clinical Pathology, 2000
- Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinomaInternational Journal of Cancer, 1998
- A Clinicopathologic Study of Nineteen True Mesothelial Neoplasms, Other Than Adenomatoid Tumors, Multicystic Mesotheliomas, and Localized Fibrous TumorsThe American Journal of Surgical Pathology, 1995
- SirHistopathology, 1993
- Diffuse Epithelial Mesothelioma: A Review of the Ultrastructural SpectrumUltrastructural Pathology, 1987